Focus on high-risk PCI

Learning Objectives

  • To understand the current strategic approaches to high-risk PCI
  • To understand how to integrate the new antiplatelet and antithrombotic agents in decision making in the Asia-Pacific region
  • To understand the technical strategy for high-risk PCI patients

Presentations available when logged in:

  • Prasugrel and Ticagrelor: will it change our practice?
  • Is there still a role for GP IIb/IIIa inhibitors?
  • PCI in ACS patients with high bleeding risk